ICU Medical, Inc. $ICUI Shares Bought by Intech Investment Management LLC

Intech Investment Management LLC boosted its position in ICU Medical, Inc. (NASDAQ:ICUI – Free Report) by 49.7% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 15,928 shares of the medical instruments supplier’s stock after acquiring an additional 5,288 shares during the period. Intech Investment Management LLC’s holdings in ICU Medical were worth $2,557,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in ICUI. BlackRock Inc. purchased a new stake in ICU Medical during the second quarter valued at about $550,250,000. Jupiter Topco LLC bought a new position in ICU Medical during the second quarter worth about $407,786,000. Janus Henderson Group PLC increased its stake in shares of ICU Medical by 3.9% in the first quarter. Janus Henderson Group PLC now owns 2,676,012 shares of the medical instruments supplier’s stock worth $345,607,000 after purchasing an additional 99,256 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in shares of ICU Medical by 6.8% in the first quarter. Dimensional Fund Advisors LP now owns 983,802 shares of the medical instruments supplier’s stock worth $127,053,000 after purchasing an additional 63,026 shares in the last quarter. Finally, Bank of America Corp DE purchased a new position in shares of ICU Medical in the second quarter worth about $54,059,000. 96.10% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts have recently issued reports on ICUI shares. Piper Sandler boosted their price target on shares of ICU Medical from $195.00 to $200.00 and gave the company an “overweight” rating in a research report on Friday, November 6th. Needham & Company LLC raised their price objective on shares of ICU Medical from $165.00 to $187.00 and gave the stock a “buy” rating in a report on Friday, August 7th. Weiss Ratings raised shares of ICU Medical from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, October 8th. Wall Street Zen upgraded shares of ICU Medical from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 8th. Finally, Zacks Research cut shares of ICU Medical from a “strong-buy” rating to a “hold” rating in a report on Tuesday, July 28th. Two research analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $195.20.

Check Out Our Latest Stock Report on ICU Medical

Insider Buying and Selling

In related news, Director Elisha Finney sold 1,700 shares of the company’s stock in a transaction that occurred on Friday, November 13th. The shares were sold at an average price of $179.00, for a total value of $304,300.00. Following the transaction, the director directly owned 4,871 shares in the company, valued at approximately $871,909. This represents a 25.87% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director David Greenberg sold 883 shares of the firm’s stock in a transaction that occurred on Friday, November 20th. The shares were sold at an average price of $176.12, for a total transaction of $155,513.96. Following the completion of the sale, the director directly owned 9,214 shares in the company, valued at $1,622,769.68. This represents a 8.75% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 7,504 shares of company stock worth $1,290,608. Insiders own 2.10% of the company’s stock.

ICU Medical Price Performance

Shares of NASDAQ ICUI opened at $172.52 on Friday. The stock’s 50-day simple moving average is $165.37 and its two-hundred day simple moving average is $150.58. ICU Medical, Inc. has a twelve month low of $113.37 and a twelve month high of $192.85. The firm has a market capitalization of $4.31 billion, a P/E ratio of 72.18, a P/E/G ratio of 2.25 and a beta of 0.88. The company has a quick ratio of 1.19, a current ratio of 2.37 and a debt-to-equity ratio of 0.52.

ICU Medical (NASDAQ:ICUI – Get Free Report) last issued its quarterly earnings results on Thursday, November 5th. The medical instruments supplier reported $2.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.14 by $0.30. The firm had revenue of $556.22 million during the quarter, compared to the consensus estimate of $552.03 million. ICU Medical had a return on equity of 8.40% and a net margin of 2.76%. The company’s revenue for the quarter was up 4.4% on a year-over-year basis. During the same quarter last year, the company posted $2.03 EPS. As a group, equities analysts anticipate that ICU Medical, Inc. will post 7.41 EPS for the current fiscal year.

ICU Medical Company Profile

(Free Report)

ICU Medical is a medical technology company that develops, manufactures and markets products used in infusion therapy, vascular access and critical care. Its offerings include infusion pumps and related sets and accessories, IV solutions, needlefree connectors, and products designed to help protect healthcare workers when handling hazardous drugs. Founded in 1984, the company expanded its product portfolio through acquisitions, including the infusion systems business of Hospira in 2017 and Smiths Medical in 2022.

Read More

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUI – Free Report).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.